HLA-G and neoplasm: Given its tumor-specific expression and immune inhibitory function and its anti-tumor efficacy further solidified by pre-clinical HLA-G-targeted in vitro and in vivo studies (17–21), HLA-G is expected to act as a promising immune checkpoint.